Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Jul 11, 2023
- Accession no.
- 0001447362-23-000118
- Filed
- Jul 11, 2023
- Trade date
- Jul 7, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 7 non-derivative transactions. Open-market sales total $503.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 7, 2023 | Common Stock | SSaleDisposed | −8,376 | $20.04F2 | −$167,855.04 | 121,813 | Direct | |
| Jul 7, 2023 | Common Stock | SSaleDisposed | −4,188 | $20.04F2 | −$83,927.52 | 107,970 | Indirect | |
| Jul 7, 2023 | Common Stock | SSaleDisposed | −4,188 | $20.04F2 | −$83,927.52 | 96,865 | Indirect | |
| Jul 7, 2023 | Common Stock | SSaleDisposed | −2,091 | $20.04F2 | −$41,903.64 | 17,430 | Indirect | |
| Jul 7, 2023 | Common Stock | SSaleDisposed | −2,091 | $20.04F2 | −$41,903.64 | 17,430 | Indirect | |
| Jul 7, 2023 | Common Stock | SSaleDisposed | −2,091 | $20.04F2 | −$41,903.64 | 17,430 | Indirect | |
| Jul 7, 2023 | Common Stock | SSaleDisposed | −2,091 | $20.04F2 | −$41,903.64 | 17,424 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $20.000 to $20.205, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.